Obesity and metabolic disease reshape longitudinal care demand
Large cardiometabolic populations create demand across obesity treatment, diabetes prevention, sleep apnea, cardiovascular risk, and durable follow-up support.
epidemiologydisease burdenopportunity sizingtherapeutic areas
Related reports
More on adjacent market questions.
Projected prevalence, age-linked risk, hospitalizations, silent disease, and anticoagulation handoffs frame AFib as a population-scale rhythm-management problem.
epidemiologydisease burdenopportunity sizing
Intelligence reportJun 7, 2026
A high-risk diabetes complication creates clinical and economic burden when neuropathy, PAD, infection, and follow-up gaps delay healing.
epidemiologydisease burdenopportunity sizing
Intelligence reportJun 7, 2026
U.S. prevalence, mortality, readmissions, aging, HFpEF, and multimorbidity frame HF as a chronic-care and transition-of-care problem.
epidemiologydisease burdenopportunity sizing
Intelligence reportJun 7, 2026